311 related articles for article (PubMed ID: 31883552)
41. Artificial Intelligence-Enabled De Novo Design of Novel Compounds that Are Synthesizable.
Bhisetti G; Fang C
Methods Mol Biol; 2022; 2390():409-419. PubMed ID: 34731479
[TBL] [Abstract][Full Text] [Related]
42. Structure-based
Li Y; Pei J; Lai L
Chem Sci; 2021 Oct; 12(41):13664-13675. PubMed ID: 34760151
[TBL] [Abstract][Full Text] [Related]
43. Deep learning approaches for de novo drug design: An overview.
Wang M; Wang Z; Sun H; Wang J; Shen C; Weng G; Chai X; Li H; Cao D; Hou T
Curr Opin Struct Biol; 2022 Feb; 72():135-144. PubMed ID: 34823138
[TBL] [Abstract][Full Text] [Related]
44. The Synthesizability of Molecules Proposed by Generative Models.
Gao W; Coley CW
J Chem Inf Model; 2020 Dec; 60(12):5714-5723. PubMed ID: 32250616
[TBL] [Abstract][Full Text] [Related]
45. Generative Models for De Novo Drug Design.
Tong X; Liu X; Tan X; Li X; Jiang J; Xiong Z; Xu T; Jiang H; Qiao N; Zheng M
J Med Chem; 2021 Oct; 64(19):14011-14027. PubMed ID: 34533311
[TBL] [Abstract][Full Text] [Related]
46. Deep Generative Models in
Pang C; Qiao J; Zeng X; Zou Q; Wei L
J Chem Inf Model; 2024 Apr; 64(7):2174-2194. PubMed ID: 37934070
[TBL] [Abstract][Full Text] [Related]
47. DNMG: Deep molecular generative model by fusion of 3D information for de novo drug design.
Song T; Ren Y; Wang S; Han P; Wang L; Li X; Rodriguez-Patón A
Methods; 2023 Mar; 211():10-22. PubMed ID: 36764588
[TBL] [Abstract][Full Text] [Related]
48. Molecular design in drug discovery: a comprehensive review of deep generative models.
Cheng Y; Gong Y; Liu Y; Song B; Zou Q
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34415297
[TBL] [Abstract][Full Text] [Related]
49. Generation of focused drug molecule library using recurrent neural network.
Zou J; Zhao L; Shi S
J Mol Model; 2023 Nov; 29(12):361. PubMed ID: 37932607
[TBL] [Abstract][Full Text] [Related]
50. Advances and Challenges in De Novo Drug Design Using Three-Dimensional Deep Generative Models.
Xie W; Wang F; Li Y; Lai L; Pei J
J Chem Inf Model; 2022 May; 62(10):2269-2279. PubMed ID: 35544331
[TBL] [Abstract][Full Text] [Related]
51. MolGPT: Molecular Generation Using a Transformer-Decoder Model.
Bagal V; Aggarwal R; Vinod PK; Priyakumar UD
J Chem Inf Model; 2022 May; 62(9):2064-2076. PubMed ID: 34694798
[TBL] [Abstract][Full Text] [Related]
52. Generative Adversarial Networks for De Novo Molecular Design.
Lee YJ; Kahng H; Kim SB
Mol Inform; 2021 Oct; 40(10):e2100045. PubMed ID: 34622551
[TBL] [Abstract][Full Text] [Related]
53. Beam Search for Automated Design and Scoring of Novel ROR Ligands with Machine Intelligence*.
Moret M; Helmstädter M; Grisoni F; Schneider G; Merk D
Angew Chem Int Ed Engl; 2021 Aug; 60(35):19477-19482. PubMed ID: 34165856
[TBL] [Abstract][Full Text] [Related]
54.
Atance SR; Diez JV; Engkvist O; Olsson S; Mercado R
J Chem Inf Model; 2022 Oct; 62(20):4863-4872. PubMed ID: 36219571
[TBL] [Abstract][Full Text] [Related]
55. Combining generative artificial intelligence and on-chip synthesis for de novo drug design.
Grisoni F; Huisman BJH; Button AL; Moret M; Atz K; Merk D; Schneider G
Sci Adv; 2021 Jun; 7(24):. PubMed ID: 34117066
[TBL] [Abstract][Full Text] [Related]
56. Graph neural networks for automated de novo drug design.
Xiong J; Xiong Z; Chen K; Jiang H; Zheng M
Drug Discov Today; 2021 Jun; 26(6):1382-1393. PubMed ID: 33609779
[TBL] [Abstract][Full Text] [Related]
57. SMILES-based deep generative scaffold decorator for de-novo drug design.
Arús-Pous J; Patronov A; Bjerrum EJ; Tyrchan C; Reymond JL; Chen H; Engkvist O
J Cheminform; 2020 May; 12(1):38. PubMed ID: 33431013
[TBL] [Abstract][Full Text] [Related]
58. Chemical language models for de novo drug design: Challenges and opportunities.
Grisoni F
Curr Opin Struct Biol; 2023 Apr; 79():102527. PubMed ID: 36738564
[TBL] [Abstract][Full Text] [Related]
59. Comparative Study of Deep Generative Models on Chemical Space Coverage.
Zhang J; Mercado R; Engkvist O; Chen H
J Chem Inf Model; 2021 Jun; 61(6):2572-2581. PubMed ID: 34015916
[TBL] [Abstract][Full Text] [Related]
60. Strategies for Design of Molecular Structures with a Desired Pharmacophore Using Deep Reinforcement Learning.
Yoshimori A; Kawasaki E; Kanai C; Tasaka T
Chem Pharm Bull (Tokyo); 2020; 68(3):227-233. PubMed ID: 32115529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
